|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Immunity
8:553-562
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes.
|
|
J.A.Speir,
K.C.Garcia,
A.Brunmark,
M.Degano,
P.A.Peterson,
L.Teyton,
I.A.Wilson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
MHC class I H-2Ld complexed with peptide QL9 (or p2Ca) is a high-affinity
alloantigen for the 2C TCR. We used the crystal structure of H-2Ld with a
mixture of bound peptides at 3.1 A to construct a model of the allogeneic
2C-Ld/QL9 complex for comparison with the syngeneic 2C-Kb/dEV8 structure. A
prominent ridge on the floor of the Ld peptide-binding groove, not present in
Kb, creates a C-terminal bulge in Ld peptides that greatly increases
interactions with the 2C beta-chain. Furthermore, weak electrostatic
complementarity between Asp77 on the alpha1 helix of Kb and 2C is enhanced in
the allogeneic complex by closer proximity of QL9 peptide residue AspP8 to the
2C HV4 loop.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Ribbon Diagram of and Peptide Binding Groove
Electron Density in the H-2L^d Crystal Structure(A) Ribbon
diagram of the H-2L^d crystal structure viewed along the
peptide-binding groove. The peptide N-terminus is shown oriented
toward the viewer. (B) The peptide electron density in the
H-2L^d crystal structure. The σ[A]-weighted 2F[o]-F[c] electron
density is viewed with the peptide (APAAAAAAM) N-terminus on the
right to show the effect of the large polymorphic residues
(e.g., Trp73, Trp97, Tyr99) on the peptide conformation.
Residues below the peptide from three of the α[1]α[2] domain
β-strands and β[2]m (Trp60) form the bottom of the
peptide-binding groove. The map is contoured at 1.5σ with a
cover radius of 2.5 Å applied.
|
 |
Figure 2.
Figure 2. Structure Comparison of Selected Class I
MHC-Bound PeptidesThe MHC allele and peptide sequence are given
above the corresponding model. The peptides were superimposed
(bottom) by aligning only the α[1]α[2] C^α atoms of the MHC
molecules. The L^d tube diameter is enlarged in this
superimposition for clarity. The K^b peptide (dEV8) is one
residue shorter (P1–P8) than the others (P1–P9).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Immunity
(1998,
8,
553-562)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Flutter,
N.Edwards,
F.Fallah-Arani,
S.Henderson,
J.G.Chai,
S.Sivakumaran,
S.Ghorashian,
C.L.Bennett,
G.J.Freeman,
M.Sykes,
and
R.Chakraverty
(2010).
Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation.
|
| |
J Clin Invest,
120,
3855-3868.
|
 |
|
|
|
|
 |
R.M.Welsh,
J.W.Che,
M.A.Brehm,
and
L.K.Selin
(2010).
Heterologous immunity between viruses.
|
| |
Immunol Rev,
235,
244-266.
|
 |
|
|
|
|
 |
N.A.Bowerman,
L.A.Colf,
K.C.Garcia,
and
D.M.Kranz
(2009).
Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides.
|
| |
J Biol Chem,
284,
32551-32561.
|
 |
|
|
|
|
 |
W.A.Macdonald,
Z.Chen,
S.Gras,
J.K.Archbold,
F.E.Tynan,
C.S.Clements,
M.Bharadwaj,
L.Kjer-Nielsen,
P.M.Saunders,
M.C.Wilce,
F.Crawford,
B.Stadinsky,
D.Jackson,
A.G.Brooks,
A.W.Purcell,
J.W.Kappler,
S.R.Burrows,
J.Rossjohn,
and
J.McCluskey
(2009).
T cell allorecognition via molecular mimicry.
|
| |
Immunity,
31,
897-908.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Z.Wang,
W.J.Shufesky,
A.Montecalvo,
S.J.Divito,
A.T.Larregina,
and
A.E.Morelli
(2009).
In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy.
|
| |
PLoS ONE,
4,
e4940.
|
 |
|
|
|
|
 |
J.K.Archbold,
W.A.Macdonald,
S.R.Burrows,
J.Rossjohn,
and
J.McCluskey
(2008).
T-cell allorecognition: a case of mistaken identity or déjà vu?
|
| |
Trends Immunol,
29,
220-226.
|
 |
|
|
|
|
 |
L.A.Colf,
A.J.Bankovich,
N.A.Hanick,
N.A.Bowerman,
L.L.Jones,
D.M.Kranz,
and
K.C.Garcia
(2007).
How a single T cell receptor recognizes both self and foreign MHC.
|
| |
Cell,
129,
135-146.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Varani,
A.J.Bankovich,
C.W.Liu,
L.A.Colf,
L.L.Jones,
D.M.Kranz,
J.D.Puglisi,
and
K.C.Garcia
(2007).
Solution mapping of T cell receptor docking footprints on peptide-MHC.
|
| |
Proc Natl Acad Sci U S A,
104,
13080-13085.
|
 |
|
|
|
|
 |
C.Douat-Casassus,
N.Marchand-Geneste,
E.Diez,
C.Aznar,
P.Picard,
S.Geoffre,
A.Huet,
M.L.Bourguet-Kondracki,
N.Gervois,
F.Jotereau,
and
S.Quideau
(2006).
Covalent modification of a melanoma-derived antigenic peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies.
|
| |
Mol Biosyst,
2,
240-249.
|
 |
|
|
|
|
 |
C.S.Hourigan,
M.Harkiolaki,
N.A.Peterson,
J.I.Bell,
E.Y.Jones,
and
C.A.O'Callaghan
(2006).
The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition.
|
| |
Eur J Immunol,
36,
3288-3293.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.K.Selin,
M.A.Brehm,
Y.N.Naumov,
M.Cornberg,
S.K.Kim,
S.C.Clute,
and
R.M.Welsh
(2006).
Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.
|
| |
Immunol Rev,
211,
164-181.
|
 |
|
|
|
|
 |
L.L.Jones,
S.E.Brophy,
A.J.Bankovich,
L.A.Colf,
N.A.Hanick,
K.C.Garcia,
and
D.M.Kranz
(2006).
Engineering and characterization of a stabilized alpha1/alpha2 module of the class I major histocompatibility complex product Ld.
|
| |
J Biol Chem,
281,
25734-25744.
|
 |
|
|
|
|
 |
M.G.Rudolph,
R.L.Stanfield,
and
I.A.Wilson
(2006).
How TCRs bind MHCs, peptides, and coreceptors.
|
| |
Annu Rev Immunol,
24,
419-466.
|
 |
|
|
|
|
 |
D.M.Zajonc,
C.Cantu,
J.Mattner,
D.Zhou,
P.B.Savage,
A.Bendelac,
I.A.Wilson,
and
L.Teyton
(2005).
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.
|
| |
Nat Immunol,
6,
810-818.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.A.Aronica,
and
N.Vogel
(2005).
Pathogens and immunologic memory in asthma: what have we learned?
|
| |
Expert Rev Clin Immunol,
1,
589-601.
|
 |
|
|
|
|
 |
N.A.Borg,
L.K.Ely,
T.Beddoe,
W.A.Macdonald,
H.H.Reid,
C.S.Clements,
A.W.Purcell,
L.Kjer-Nielsen,
J.J.Miles,
S.R.Burrows,
J.McCluskey,
and
J.Rossjohn
(2005).
The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
|
| |
Nat Immunol,
6,
171-180.
|
 |
|
|
|
|
 |
C.Kellenberger,
S.Porciero,
and
A.Roussel
(2004).
Expression, refolding, crystallization and preliminary crystallographic study of MHC H-2Kk complexed with octapeptides and nonapeptides.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
1278-1280.
|
 |
|
|
|
|
 |
G.G.Capps,
S.Pine,
M.Edidin,
and
M.C.Zúñiga
(2004).
Short class I major histocompatibility complex cytoplasmic tails differing in charge detect arbiters of lateral diffusion in the plasma membrane.
|
| |
Biophys J,
86,
2896-2909.
|
 |
|
|
|
|
 |
J.R.Neilson,
M.M.Winslow,
E.M.Hur,
and
G.R.Crabtree
(2004).
Calcineurin B1 is essential for positive but not negative selection during thymocyte development.
|
| |
Immunity,
20,
255-266.
|
 |
|
|
|
|
 |
L.K.Selin,
M.Cornberg,
M.A.Brehm,
S.K.Kim,
C.Calcagno,
D.Ghersi,
R.Puzone,
F.Celada,
and
R.M.Welsh
(2004).
CD8 memory T cells: cross-reactivity and heterologous immunity.
|
| |
Semin Immunol,
16,
335-347.
|
 |
|
|
|
|
 |
L.K.Selin,
and
R.M.Welsh
(2004).
Plasticity of T cell memory responses to viruses.
|
| |
Immunity,
20,
5.
|
 |
|
|
|
|
 |
V.Apostolopoulos,
and
E.Lazoura
(2004).
Noncanonical peptides in complex with MHC class I.
|
| |
Expert Rev Vaccines,
3,
151-162.
|
 |
|
|
|
|
 |
A.B.Adams,
T.C.Pearson,
and
C.P.Larsen
(2003).
Heterologous immunity: an overlooked barrier to tolerance.
|
| |
Immunol Rev,
196,
147-160.
|
 |
|
|
|
|
 |
A.Hamrouni,
A.Aublin,
P.Guillaume,
and
J.L.Maryanski
(2003).
T cell receptor gene rearrangement lineage analysis reveals clues for the origin of highly restricted antigen-specific repertoires.
|
| |
J Exp Med,
197,
601-614.
|
 |
|
|
|
|
 |
B.Malissen
(2003).
Glimpses at TCR trans-species crossreactivity.
|
| |
Immunity,
19,
463-464.
|
 |
|
|
|
|
 |
D.Housset,
and
B.Malissen
(2003).
What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity?
|
| |
Trends Immunol,
24,
429-437.
|
 |
|
|
|
|
 |
P.D.Holler,
and
D.M.Kranz
(2003).
Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation.
|
| |
Immunity,
18,
255-264.
|
 |
|
|
|
|
 |
J.G.Luz,
M.Huang,
K.C.Garcia,
M.G.Rudolph,
V.Apostolopoulos,
L.Teyton,
and
I.A.Wilson
(2002).
Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.
|
| |
J Exp Med,
195,
1175-1186.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.G.Rudolph,
and
I.A.Wilson
(2002).
The specificity of TCR/pMHC interaction.
|
| |
Curr Opin Immunol,
14,
52-65.
|
 |
|
|
|
|
 |
M.G.Rudolph,
J.G.Luz,
and
I.A.Wilson
(2002).
Structural and thermodynamic correlates of T cell signaling.
|
| |
Annu Rev Biophys Biomol Struct,
31,
121-149.
|
 |
|
|
|
|
 |
P.E.Adrian,
G.Rajaseger,
V.S.Mathura,
M.K.Sakharkar,
and
P.Kangueane
(2002).
Types of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated data.
|
| |
BMC Struct Biol,
2,
2.
|
 |
|
|
|
|
 |
A.Guimezanes,
G.A.Barrett-Wilt,
P.Gulden-Thompson,
J.Shabanowitz,
V.H.Engelhard,
D.F.Hunt,
A.M.Schmitt-Verhulst,
and
V.H.Engelhardt
(2001).
Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: distinct characteristics correlated with CD8 dependence.
|
| |
Eur J Immunol,
31,
421-432.
|
 |
|
|
|
|
 |
A.Qadri,
and
E.S.Ward
(2001).
Activation of a T cell hybridoma by an alloligand results in differential effects on IL-2 secretion and activation-induced cell death.
|
| |
Eur J Immunol,
31,
3825-3832.
|
 |
|
|
|
|
 |
B.M.Baker,
R.V.Turner,
S.J.Gagnon,
D.C.Wiley,
and
W.E.Biddison
(2001).
Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors.
|
| |
J Exp Med,
193,
551-562.
|
 |
|
|
|
|
 |
J.Hennecke,
and
D.C.Wiley
(2001).
T cell receptor-MHC interactions up close.
|
| |
Cell,
104,
1-4.
|
 |
|
|
|
|
 |
M.B.Oldstone,
H.Lewicki,
D.Homann,
C.Nguyen,
S.Julien,
and
J.E.Gairin
(2001).
Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses.
|
| |
J Virol,
75,
6273-6278.
|
 |
|
|
|
|
 |
M.G.Rudolph,
J.A.Speir,
A.Brunmark,
N.Mattsson,
M.R.Jackson,
P.A.Peterson,
L.Teyton,
and
I.A.Wilson
(2001).
The crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity.
|
| |
Immunity,
14,
231-242.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.D.Holler,
A.R.Lim,
B.K.Cho,
L.A.Rund,
and
D.M.Kranz
(2001).
CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation.
|
| |
J Exp Med,
194,
1043-1052.
|
 |
|
|
|
|
 |
X.C.Xu,
T.Howard,
and
T.Mohanakumar
(2001).
Tissue-specific peptides influence human T cell repertoire to porcine xenoantigens.
|
| |
Transplantation,
72,
1205-1212.
|
 |
|
|
|
|
 |
C.Wingren,
M.P.Crowley,
M.Degano,
Y.Chien,
and
I.A.Wilson
(2000).
Crystal structure of a gammadelta T cell receptor ligand T22: a truncated MHC-like fold.
|
| |
Science,
287,
310-314.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.E.Slansky,
F.M.Rattis,
L.F.Boyd,
T.Fahmy,
E.M.Jaffee,
J.P.Schneck,
D.H.Margulies,
and
D.M.Pardoll
(2000).
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.
|
| |
Immunity,
13,
529-538.
|
 |
|
|
|
|
 |
M.Degano,
K.C.Garcia,
V.Apostolopoulos,
M.G.Rudolph,
L.Teyton,
and
I.A.Wilson
(2000).
A functional hot spot for antigen recognition in a superagonist TCR/MHC complex.
|
| |
Immunity,
12,
251-261.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.J.Felix,
W.J.Brickey,
R.Griffiths,
J.Zhang,
L.Van Kaer,
T.Coffman,
and
J.P.Ting
(2000).
H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection.
|
| |
J Exp Med,
192,
31-40.
|
 |
|
|
|
|
 |
O.Schueler-Furman,
Y.Altuvia,
A.Sette,
and
H.Margalit
(2000).
Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.
|
| |
Protein Sci,
9,
1838-1846.
|
 |
|
|
|
|
 |
P.D.Holler,
P.O.Holman,
E.V.Shusta,
S.O'Herrin,
K.D.Wittrup,
and
D.M.Kranz
(2000).
In vitro evolution of a T cell receptor with high affinity for peptide/MHC.
|
| |
Proc Natl Acad Sci U S A,
97,
5387-5392.
|
 |
|
|
|
|
 |
P.U.Lee,
H.R.Churchill,
M.Daniels,
S.C.Jameson,
and
D.M.Kranz
(2000).
Role of 2CT cell receptor residues in the binding of self- and allo-major histocompatibility complexes.
|
| |
J Exp Med,
191,
1355-1364.
|
 |
|
|
|
|
 |
R.M.Welsh,
T.G.Markees,
B.A.Woda,
K.A.Daniels,
M.A.Brehm,
J.P.Mordes,
D.L.Greiner,
and
A.A.Rossini
(2000).
Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.
|
| |
J Virol,
74,
2210-2218.
|
 |
|
|
|
|
 |
R.Obst,
N.Netuschil,
K.Klopfer,
S.Stevanović,
and
H.G.Rammensee
(2000).
The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.
|
| |
J Exp Med,
191,
805-812.
|
 |
|
|
|
|
 |
J.A.Speir,
U.M.Abdel-Motal,
M.Jondal,
and
I.A.Wilson
(1999).
Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL.
|
| |
Immunity,
10,
51-61.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Thatte,
A.Qadri,
C.Radu,
and
E.S.Ward
(1999).
Molecular requirements for T cell recognition by a major histocompatibility complex class II-restricted T cell receptor: the involvement of the fourth hypervariable loop of the Valpha domain.
|
| |
J Exp Med,
189,
509-520.
|
 |
|
|
|
|
 |
K.C.Garcia,
L.Teyton,
and
I.A.Wilson
(1999).
Structural basis of T cell recognition.
|
| |
Annu Rev Immunol,
17,
369-397.
|
 |
|
|
|
|
 |
K.C.Garcia
(1999).
Molecular interactions between extracellular components of the T-cell receptor signaling complex.
|
| |
Immunol Rev,
172,
73-85.
|
 |
|
|
|
|
 |
K.Maenaka,
and
E.Y.Jones
(1999).
MHC superfamily structure and the immune system.
|
| |
Curr Opin Struct Biol,
9,
745-753.
|
 |
|
|
|
|
 |
Q.R.Fan,
and
D.C.Wiley
(1999).
Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.
|
| |
J Exp Med,
190,
113-123.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.N.Germain,
and
I.Stefanová
(1999).
The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation.
|
| |
Annu Rev Immunol,
17,
467-522.
|
 |
|
|
|
|
 |
R.Zhao,
D.J.Loftus,
E.Appella,
and
E.J.Collins
(1999).
Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry.
|
| |
J Exp Med,
189,
359-370.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.C.Manning,
E.A.Parke,
L.Teyton,
and
D.M.Kranz
(1999).
Effects of complementarity determining region mutations on the affinity of an alpha/beta T cell receptor: measuring the energy associated with CD4/CD8 repertoire skewing.
|
| |
J Exp Med,
189,
461-470.
|
 |
|
|
|
|
 |
T.C.Manning,
C.J.Schlueter,
T.C.Brodnicki,
E.A.Parke,
J.A.Speir,
K.C.Garcia,
L.Teyton,
I.A.Wilson,
and
D.M.Kranz
(1998).
Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition.
|
| |
Immunity,
8,
413-425.
|
 |
|
|
|
|
 |
Y.Sykulev,
Y.Vugmeyster,
A.Brunmark,
H.L.Ploegh,
and
H.N.Eisen
(1998).
Peptide antagonism and T cell receptor interactions with peptide-MHC complexes.
|
| |
Immunity,
9,
475-483.
|
 |
|
|
|
|
 |
Z.Cai,
A.B.Brunmark,
A.T.Luxembourg,
K.C.Garcia,
M.Degano,
L.Teyton,
I.Wilson,
P.A.Peterson,
J.Sprent,
and
M.R.Jackson
(1998).
Probing the activation requirements for naive CD8+ T cells with Drosophila cell transfectants as antigen presenting cells.
|
| |
Immunol Rev,
165,
249-265.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |